Zobrazeno 1 - 10
of 152
pro vyhledávání: '"anti‐tachycardia pacing therapy"'
Autor:
Okada, Jun‐ichi1,2 okada@sml.k.u-tokyo.ac.jp, Washio, Takumi1,2, Sugiura, Seiryo1, Hisada, Toshiaki1
Publikováno v:
Pacing & Clinical Electrophysiology. Dec2023, Vol. 46 Issue 12, p1509-1518. 10p.
Autor:
Qian, Shuang, Connolly, Adam, Mendonca-Costa, Caroline, Campos, Fernando, Williams, Steven E., Whitaker, John, Rinaldi, Christopher A., Bishop, Martin J.
Publikováno v:
In Computers in Biology and Medicine December 2021 139
Autor:
Shakibfar, Saeed1, Krause, Oswin1, Lund-Andersen, Casper2, Strycko, Filip1, Moll, Jonas1, Osman Andersen, Tariq1, Høgh Petersen, Helen2, Hastrup Svendsen, Jesper2,3, Igel, Christian1 igel@diku.dk
Publikováno v:
PLoS ONE. 8/8/2019, Vol. 14 Issue 8, p1-7. 7p.
Autor:
Saeed Shakibfar, Oswin Krause, Casper Lund-Andersen, Filip Strycko, Jonas Moll, Tariq Osman Andersen, Helen Høgh Petersen, Jesper Hastrup Svendsen, Christian Igel
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0219533 (2019)
BackgroundAntitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). We evaluated the efficacy of different ATP programs based on a large remote monitoring data set from patients with implantable cardioverter-defibrillat
Externí odkaz:
https://doaj.org/article/ba87efa5fba544b491a6814b9ad4828a
Autor:
Adam Connolly, Shuang Qian, Fernando O. Campos, Caroline Mendonca-Costa, John Whitaker, Steven Williams, Martin J. Bishop, Christopher A. Rinaldi
Publikováno v:
Computers in Biology and Medicine
The implanted cardioverter defibrillator (ICD) is an effective direct therapy for the treatment of cardiac arrhythmias, including ventricular tachycardia (VT). Anti-tachycardia pacing (ATP) is often applied by the ICD as the first mode of therapy, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c4a3919a0f371f5db2793ebbf4033c
https://doi.org/10.1016/j.compbiomed.2021.104987
https://doi.org/10.1016/j.compbiomed.2021.104987
Autor:
Jonas Moll, Tariq Osman Andersen, Casper Lund-Andersen, Christian Igel, Filip Strycko, Saeed Shakibfar, Jesper Hastrup Svendsen, Helen Høgh Petersen, Oswin Krause
Publikováno v:
Shakibfar, S, Krause, O, Lund-Andersen, C, Strycko, F, Moll, J, Osman Andersen, T, Høgh Petersen, H, Hastrup Svendsen, J & Igel, C 2019, ' Impact of device programming on the success of the first anti-tachycardia pacing therapy : An anonymized large-scale study ', PLoS ONE, vol. 14, no. 8, e0219533 . https://doi.org/10.1371/journal.pone.0219533
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0219533 (2019)
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0219533 (2019)
BACKGROUND: Antitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). We evaluated the efficacy of different ATP programs based on a large remote monitoring data set from patients with implantable cardioverter-defibrill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aae84a373f6153f47c430f81d705c39
https://curis.ku.dk/portal/da/publications/impact-of-device-programming-on-the-success-of-the-first-antitachycardia-pacing-therapy(cd16572e-69f7-43da-bf61-1ddb78104df5).html
https://curis.ku.dk/portal/da/publications/impact-of-device-programming-on-the-success-of-the-first-antitachycardia-pacing-therapy(cd16572e-69f7-43da-bf61-1ddb78104df5).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Keita Tsukahara, Yasushi Oginosawa, Yoshihisa Fujino, Toshihiro Honda, Kan Kikuchi, Masatsugu Nozoe, Takayuki Uchida, Hitoshi Minamiguchi, Koichiro Sonoda, Masahiro Ogawa, Takeshi Ideguchi, Yoshihisa Kizaki, Toshihiro Nakamura, Kageyuki Oba, Satoshi Higa, Keiki Yoshida, Keishiro Yagyu, Taro Miyamoto, Yasunobu Yamagishi, Hisaharu Ohe, Ritsuko Kohno, Masaharu Kataoka, Yutaka Otsuji, Haruhiko Abe
Publikováno v:
Journal of Arrhythmia, Vol 37, Iss 4, Pp 1052-1060 (2021)
Abstract Background An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic device for preventing sudden cardiac death in patients with sustained ventricular tachycardia (VT). Regarding its effectiveness, targeted VT is defin
Externí odkaz:
https://doaj.org/article/e3cec7acbd80414bbd7957c0c48e0c33
Publikováno v:
Zhonghua xin xue guan bing za zhi. 33(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::569b3dc4b41cc3b7e7a2e71177737f02
https://pubmed.ncbi.nlm.nih.gov/16053794
https://pubmed.ncbi.nlm.nih.gov/16053794